Canada

The fund, backed by existing and new LPs, gives the firm $1.5bn in total AUM. Partner Chris Arsenault says the firm came to market with the vehicle sooner than expected.

Secondaries has maintained a steady pace so far this year, though several sources have seen a lull in new offerings hitting the market.

Keeping tabs on what some of last year's roster have been up to.

The pandemic might have had a beneficial effect on fundraising by “highlighting how impactful healthcare innovation can be,” Sagard's David MacNaughtan told Buyouts.

Fund VI was “very significantly oversubscribed,” president and CEO Pascal Tremblay told Buyouts, with Novacap “more than doubling” the size of its investor base.

Brookfield’s fundraising plans include a debut energy transition offering with a target of more than $7.5bn. The firm is committing $2bn.

Patterson, one of OMERS Private Equity's six senior managing directors, led or co-led some of the group's best-known healthcare investments.

Blackstone joins TPG as the latest high-profile GP to raise a separate fund for GP-led secondaries.

The process fell apart once the pandemic broke out and markets shut, which had an impact on CAA’s business with live events and entertainment production delayed and canceled.

Sagard launched its credit strategy in 2017 under the leadership of managing partner and CIO Adam Vigna, ex-head of CPPIB’s global principal credit investments.